These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19922547)

  • 1. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
    Barski D; Wolter M; Reifenberger G; Riemenschneider MJ
    Brain Pathol; 2010 May; 20(3):623-31. PubMed ID: 19922547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
    Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
    Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
    J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
    Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
    J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of hMLH1 hypermethylation and microsatellite instability in meningioma progression.
    Chen MN; Wang P; Zhang J; Zhou BY; Mao Q; Liu YH
    Genet Mol Res; 2012 Nov; 11(4):3933-41. PubMed ID: 22930430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss on chromosomes 1p32, 9p21, 13q14, 16q22, 17p, and 22q12 in meningiomas associated with meningioangiomatosis and pure meningioangiomatosis.
    Kim NR; Cho SJ; Suh YL
    J Neurooncol; 2009 Sep; 94(3):425-30. PubMed ID: 19347254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of meningiomas.
    Ragel BT; Jensen RL
    Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas].
    Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic alterations in meningiomas.
    Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
    Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of beta-catenin/E-cadherin in meningiomas.
    Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
    Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses in neurofibromatosis 2-associated meningiomas.
    Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
    J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
    Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
    Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.